Clinical Evaluation of QFlu Combo Test (QFlu)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01506583|
Recruitment Status : Unknown
Verified January 2012 by Cellex, Inc..
Recruitment status was: Recruiting
First Posted : January 10, 2012
Last Update Posted : January 10, 2012
|Condition or disease|
|Cough Myalgia Nasal Obstruction Sore Throat Headache Fatigue Fever|
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Clinical Evaluation of QFlu Combo Test|
|Study Start Date :||November 2010|
|Estimated Primary Completion Date :||May 2012|
|Estimated Study Completion Date :||July 2012|
This group of participants is primarily an out-patient population.
This group of participants is primarily an in-patient population.
Participants in this group are children 18 years or younger.
- Sensitivity and specificity for drug resistance detection [ Time Frame: approximately 12 months after the study is completed. ]Interim results may be assessed after the first year study.
- Sensitivity and Specificity of the Test for Influenza Diagnosis [ Time Frame: 12 months after the study is completed. ]Results may be assessed after the first year study.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01506583
|United States, Alabama|
|University of Alabama at Birmingham||Recruiting|
|Birmingham, Alabama, United States, 35294|
|Contact: David Kimberlin, M.D. 205-934-5316 firstname.lastname@example.org|
|Contact: Dusty Giles, R.N. 205-934-7807 email@example.com|
|Principal Investigator: David Kimberlin, M.D.|
|United States, Illinois|
|Northwestern University Feinberg School of Medicine||Recruiting|
|Chicago, Illinois, United States, 61611|
|Contact: Mike Ison, M.S., M.D. 312-695-4186 firstname.lastname@example.org|
|Principal Investigator: Mike Ison, M.S., M.D.|
|United States, Maryland|
|University of Maryland School of Medicine||Completed|
|Baltimore, Maryland, United States, 21201|